These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8615485)

  • 21. Trimetazidine may protect the myocardium during cardiac surgery.
    Iskesen I; Kurdal AT; Eserdag M; Cerrahoglu M; Sirin BH
    Heart Surg Forum; 2009 Jun; 12(3):E175-9. PubMed ID: 19546072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition.
    Fragasso G; Montano C; Perseghin G; Palloshi A; Calori G; Lattuada G; Oggionni S; Bassanelli G; Locatelli M; Lopaschuk G; Margonato A
    Am Heart J; 2006 Jun; 151(6):1238.e1-8. PubMed ID: 16781225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effects of heparin administration on the ischemic threshold of patients with coronary artery disease: evaluation of the protective role of the metabolic modulator trimetazidine.
    Fragasso G; Piatti PM; Monti L; Palloshi A; Lu C; Valsecchi G; Setola E; Calori G; Pozza G; Margonato A; Chierchia S
    J Am Coll Cardiol; 2002 Feb; 39(3):413-9. PubMed ID: 11823078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aortic and mitral valve surgery on the beating heart is lowering cardiopulmonary bypass and aortic cross clamp time.
    Gersak B; Sutlic Z
    Heart Surg Forum; 2002; 5(2):182-6. PubMed ID: 12125670
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of trimetazidine in nonischemic heart failure: a randomized study.
    Winter JL; Castro PF; Quintana JC; Altamirano R; Enriquez A; Verdejo HE; Jalil JE; Mellado R; Concepción R; Sepúlveda P; Rossel V; Sepúlveda L; Chiong M; García L; Lavandero S
    J Card Fail; 2014 Mar; 20(3):149-54. PubMed ID: 24412523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing Hemodynamic Responses to Diazepam, Propofol and Etomidate During Anesthesia Induction in Patients with Left Ventricular Dysfunction Undergoing Coronary Artery Bypass Graft Surgery: a Double-blind, Randomized Clinical Trial.
    Soleimani A; Heidari N; Habibi MR; Kiabi FH; Khademloo M; Emami Zeydi A; Sohrabi FB
    Med Arch; 2017 Jun; 71(3):198-203. PubMed ID: 28974833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trimetazidine pretreatment inhibits myocardial apoptosis and improves cardiac function in a Swine model of coronary microembolization.
    Liu YC; Li L; Su Q; Liu T; Tang ZL
    Cardiology; 2015; 130(2):130-6. PubMed ID: 25612843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of adenosine-regulating agent acadesine on morbidity and mortality associated with coronary artery bypass grafting: the RED-CABG randomized controlled trial.
    Newman MF; Ferguson TB; White JA; Ambrosio G; Koglin J; Nussmeier NA; Pearl RG; Pitt B; Wechsler AS; Weisel RD; Reece TL; Lira A; Harrington RA;
    JAMA; 2012 Jul; 308(2):157-64. PubMed ID: 22782417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function.
    Eriksson HI; Jalonen JR; Heikkinen LO; Kivikko M; Laine M; Leino KA; Kuitunen AH; Kuttila KT; Peräkylä TK; Sarapohja T; Suojaranta-Ylinen RT; Valtonen M; Salmenperä MT
    Ann Thorac Surg; 2009 Feb; 87(2):448-54. PubMed ID: 19161758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The supportive value of pre-bypass L-glutamate loading in patients undergoing coronary artery bypass grafting.
    Bitzikas G; Papakonstantinou C; Lazou A; Bougioukas G; Toumpouras M; Tripsianis G; Spanos P
    J Cardiovasc Surg (Torino); 2005 Dec; 46(6):551-7. PubMed ID: 16424843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of trimetazidine on heart rate variability in patients with slow coronary artery flow.
    Topal E; Ozdemir R; Barutcu I; Aksoy Y; Sincer I; Akturk E; Cehreli S
    J Electrocardiol; 2006 Apr; 39(2):211-8. PubMed ID: 16580422
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coenzyme Q10 combined with trimetazidine in the prevention of contrast-induced nephropathy in patients with coronary heart disease complicated with renal dysfunction undergoing elective cardiac catheterization: a randomized control study and in vivo study.
    Chen F; Liu F; Lu J; Yang X; Xiao B; Jin Y; Zhang J
    Eur J Med Res; 2018 May; 23(1):23. PubMed ID: 29776437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deferoxamine infusion during coronary artery bypass grafting ameliorates lipid peroxidation and protects the myocardium against reperfusion injury: immediate and long-term significance.
    Paraskevaidis IA; Iliodromitis EK; Vlahakos D; Tsiapras DP; Nikolaidis A; Marathias A; Michalis A; Kremastinos DT
    Eur Heart J; 2005 Feb; 26(3):263-70. PubMed ID: 15618054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of pyridoxal 5'-phosphate (MC-1) in high-risk patients undergoing coronary artery bypass graft surgery: the MEND-CABG II randomized clinical trial.
    ; Alexander JH; Emery RW; Carrier M; Ellis SJ; Mehta RH; Hasselblad V; Menasche P; Khalil A; Cote R; Bennett-Guerrero E; Mack MJ; Schuler G; Harrington RA; Tardif JC
    JAMA; 2008 Apr; 299(15):1777-87. PubMed ID: 18381567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desflurane preconditioning in coronary artery bypass graft surgery: a double-blinded, randomised and placebo-controlled study.
    Meco M; Cirri S; Gallazzi C; Magnani G; Cosseta D
    Eur J Cardiothorac Surg; 2007 Aug; 32(2):319-25. PubMed ID: 17574858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline reduces cardiac matrix metalloproteinase-2 activity but does not ameliorate myocardial dysfunction during reperfusion in coronary artery bypass patients undergoing cardiopulmonary bypass.
    Schulze CJ; Castro MM; Kandasamy AD; Cena J; Bryden C; Wang SH; Koshal A; Tsuyuki RT; Finegan BA; Schulz R
    Crit Care Med; 2013 Nov; 41(11):2512-20. PubMed ID: 23928836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of trimetazidine on myocardial perfusion and the contractile response of chronically dysfunctional myocardium in ischemic cardiomyopathy: a 24-month study.
    El-Kady T; El-Sabban K; Gabaly M; Sabry A; Abdel-Hady S
    Am J Cardiovasc Drugs; 2005; 5(4):271-8. PubMed ID: 15984909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attenuation of myocardial ischemia-reperfusion injury by trimetazidine derivatives functionalized with antioxidant properties.
    Kutala VK; Khan M; Mandal R; Ganesan LP; Tridandapani S; Kalai T; Hideg K; Kuppusamy P
    J Pharmacol Exp Ther; 2006 Jun; 317(3):921-8. PubMed ID: 16467453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.